BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28846108)

  • 1. Runx3 plays a critical role in restriction-point and defense against cellular transformation.
    Chi XZ; Lee JW; Lee YS; Park IY; Ito Y; Bae SC
    Oncogene; 2017 Dec; 36(50):6884-6894. PubMed ID: 28846108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
    Lee YS; Lee JW; Jang JW; Chi XZ; Kim JH; Li YH; Kim MK; Kim DM; Choi BS; Kim EG; Chung JH; Lee OJ; Lee YM; Suh JW; Chuang LS; Ito Y; Bae SC
    Cancer Cell; 2013 Nov; 24(5):603-16. PubMed ID: 24229708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of RUNX3 in Restriction Point Regulation.
    Lee JW; Lee YS; Kim MK; Chi XZ; Kim D; Bae SC
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
    Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
    [No Abstract]   [Full Text] [Related]  

  • 6. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
    Carbone CJ; Graña X; Reddy EP; Haines DS
    Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
    Brugarolas J; Bronson RT; Jacks T
    J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
    Iwatani K; Fujimoto T; Ito T
    Biochem Biophys Res Commun; 2010 Sep; 400(3):426-31. PubMed ID: 20801098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point.
    Lee JW; Kim DM; Jang JW; Park TG; Song SH; Lee YS; Chi XZ; Park IY; Hyun JW; Ito Y; Bae SC
    Nat Commun; 2019 Apr; 10(1):1897. PubMed ID: 31015486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.
    Lee JY; Lee JW; Park TG; Han SH; Yoo SY; Jung KM; Kim DM; Lee OJ; Kim D; Chi XZ; Kim EG; Lee YS; Bae SC
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.
    Zwicker J; Brüsselbach S; Jooss KU; Sewing A; Behn M; Lucibello FC; Müller R
    Oncogene; 1999 Jan; 18(1):19-25. PubMed ID: 9926916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.
    Vormer TL; Foijer F; Wielders CL; te Riele H
    Mol Cell Biol; 2008 Dec; 28(24):7263-73. PubMed ID: 18936168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
    Santiago FS; Ishii H; Shafi S; Khurana R; Kanellakis P; Bhindi R; Ramirez MJ; Bobik A; Martin JF; Chesterman CN; Zachary IC; Khachigian LM
    Circ Res; 2007 Jul; 101(2):146-55. PubMed ID: 17556661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
    Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.
    Lee KS; Lee YS; Lee JM; Ito K; Cinghu S; Kim JH; Jang JW; Li YH; Goh YM; Chi XZ; Wee H; Lee HW; Hosoya A; Chung JH; Jang JJ; Kundu JK; Surh YJ; Kim WJ; Ito Y; Jung HS; Bae SC
    Oncogene; 2010 Jun; 29(23):3349-61. PubMed ID: 20228843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
    Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.